“…The significant differential expression between normal and tumour tissues suggested that these genes can serve as hallmark diagnostic markers for various cancers. These observations are in line with previous reports describing overexpression of MNX1 in cancers of the colon [ 15 ], breast [ 11 , 12 ], prostate [ 13 ], and glioma [ 17 ], as well as MNX1 - AS1 in breast [ 28 ], colon [ 29 ], oesophageal [ 30 ], stomach [ 31 ], glioblastoma [ 32 ], liver [ 33 ], lung [ 34 ], ovarian [ 35 , 36 ], and prostate [ 37 ] tumours. MNX1 was not found to be significantly overexpressed in liver cancer samples from TCGA compared to healthy liver tissue from GTEx, despite reports of upregulation in hepatocellular carcinoma [ 18 ].…”